September 2023
171 articles-
Sep 29 · 01:00Biotechnology Daily
Roche drops solid tumor option, intensifying the squeeze on SQZ
-
Sep 29 · 00:57Biotechnology Daily
New mRNA vaccine for malaria uses cancer immunotherapy adjuvant to improve efficacy
-
Sep 29 · 00:55Biotechnology Daily
With updated FDA nod, BD aims to revive beleaguered Alaris infusion pumps
-
Sep 29 · 00:54Biotechnology Daily
To prevent cancer metastasis, prevent protein migration, new study suggests
-
Sep 29 · 00:52Bio Business News
Humanigen mulls bankruptcy after reverse merger falls through
-
Sep 29 · 00:51Bio Business News
Heron lays off 25% of employees and renegotiates vendor contracts to save money
-
Sep 29 · 00:49Bio Business News
Roche signs onto Alnylam's midstage hypertension med for $310M upfront
-
Sep 29 · 00:47Bio Business News
Philips ekes out a profit for the first time in over a year, though orders continue to drop
-
Sep 29 · 00:09Market Watch
IonQ Shares Rise 7% After New $25.5 Million Contract
-
Sep 28 · 00:21Biotechnology Daily
Amgen's lupus bets continue to flounder, even those on the Horizon
-
Sep 28 · 00:19Biotechnology Daily
'Unexpected' cataracts in phase 3 trials end Kodiak's hopes for eye drug, halving stock price
-
Sep 28 · 00:16Biotechnology Daily
'An unexpected outcome': Bavarian Nordic crashes out of RSV race as vaccine fails phase 3 trial
-
Sep 28 · 00:14Biotechnology Daily
University of Utah's Bone Bolt system for complex fractures earns FDA clearance
-
Sep 28 · 00:12Bio Business News
The Infinity-MEI merger saga finally ends in shareholders sinking the deal
-
Sep 28 · 00:10Bio Business News
Galen Robotics nets FDA de novo clearance for ENT surgery helper
-
Sep 28 · 00:08Bio Business News
Pfizer drops sickle cell disease collab with Syros inherited from GBT takeover
-
Sep 28 · 00:06Bio Business News
Gilead's $4.9B CD47 bet faces latest setback as company cans MDS ambitions for magrolimab
-
Sep 27 · 01:25Biotechnology Daily
Sleepless nights for 500 Idorsia staff as biotech halves cash burn to outlast weak insomnia drug sales
-
Sep 27 · 01:22Biotechnology Daily
Ex-B. Braun regulatory specialist pleads guilty to forging FDA clearance documents
-
Sep 27 · 01:19Biotechnology Daily
Passage decides 26% of staff, 2 execs not needed on voyage deeper into clinic
-
Sep 27 · 01:12Bio Business News
Turnstone Biologics turns fortunes around with $80M IPO haul
-
Sep 27 · 01:06Bio Business News
J&J's shrinking infectious disease and vaccine plans leave partners in limbo
-
Sep 27 · 01:03Bio Business News
Intuitive stock slumps on Q2 results—even as robotic surgery procedures continue post-pandemic recovery
-
Sep 27 · 01:02Bio Business News
ViewRay looks to sell MRI-guided radiotherapy tech in wake of bankruptcy filing